SciSure acquires Labfolder (ELN) and Labregister (inventory) from Labforward, expanding its Scientific Management Platform for connected science.
Berlin, Germany, September 04, 2025 – SciSure, announced the acquisition of Labfolder and Labregister, two flagship products from Labforward, reinforcing its commitment to create the home base for connected and reproducible science.
Why This Matters for Science
This acquisition deepens SciSure’s ability to serve modern laboratories with flexible, scientist-friendly solutions that integrate directly into research workflows.
– Labfolder (ELN) and Labregister (inventory) will now operate under the SciSure brand.
– Together, they expand SciSure’s Scientific Management Platform (SMP), the only system designed to unify research documentation, inventory management, and compliance tracking without adding administrative burden.
– SciSure, Labfolder, and Labregister stand out as the only globally available platforms with full German language support, further strengthening SciSure’s commitment to the German research community.
Leadership Perspectives
“Labfolder and Labregister are trusted by scientists around the world to capture experiments and manage lab resources,” said Philip Meer, CEO of SciSure. “Bringing these products and the talented team together with SciSure will accelerate innovation and expand choice for our valued customers, particularly those in Germany who have come to rely on a local presence for guidance and support. This acquisition brings us one step closer to fulfilling our mission: to facilitate unburdened, uncompromised, safe, and sustainable scientific advancement.”
The Bigger Picture
This acquisition allows SciSure to bring together the people, expertise, and partner network behind Labfolder and Labregister with their own team. By combining resources in this way, SciSure can accelerate innovation and strengthen its ability to serve scientists, lab managers, and compliance officers worldwide. The move reinforces SciSure’s commitment to building a Scientific Management Platform that not only advances research integrity and compliance but also draws on the best talent and partnerships in the industry.
Looking Ahead
As SciSure continues to build the Scientific Management Platform labs deserve, this acquisition marks another milestone in its vision: a unified, future-ready system that integrates ELN, LIMS, inventory, safety, compliance, and risk management into simplified workflows, enabling science to move forward, faster.
About SciSure
Trusted by over 1,000 customers worldwide, SciSure is an award-winning Scientific Management Platform (SMP) that unifies ELN, LIMS, EHS, and integrations into a single solution. Formed through the merger of SciShield and eLabNext, SciSure brings together decades of expertise in lab digitization and compliance. Recognized for product innovation and customer satisfaction, SciSure supports scientists, lab operations, and compliance teams in delivering operational excellence and research integrity. Learn more at www.scisure.com.
About Strattam Capital
Strattam Capital is a private equity firm with over $1 billion in assets under management, investing in founder-led, B2B software and technology companies that are poised to become vertical market leaders.
Strattam’s values of transparency, continuous improvement, and carrying forward the ownership mindset of founders led to the creation of The Five-Point Plan, an investment process that emphasizes aligning with founders before signing. The firm supports portfolio company leaders in building their teams, extending their reach, and adopting new technologies—today, AI—to solve the customer problems they understand so well.
Founded in 2014, Strattam is based in Austin and San Francisco. Since inception, the firm has completed more than 50 partnerships with founder-led businesses.
SOURCE SciSure